about
Reassessing the role of the secreted protease CPAF in Chlamydia trachomatis infection through genetic approachesCytopathicity of Chlamydia is largely reproduced by expression of a single chlamydial proteaseMultifunctional analysis of Chlamydia-specific genes in a yeast expression system.Chlamydial protease-like activity factor--insights into immunity and vaccine developmentMembrane vesicle production by Chlamydia trachomatis as an adaptive responseIntramolecular dimerization is required for the chlamydia-secreted protease CPAF to degrade host transcriptional factors.The Chlamydia protease CPAF regulates host and bacterial proteins to maintain pathogen vacuole integrity and promote virulenceLocalization of the hypothetical protein Cpn0797 in the cytoplasm of Chlamydia pneumoniae-infected host cells.In silico prediction and functional validation of sigma28-regulated genes in Chlamydia and Escherichia coliHypothetical protein Cpn0308 is localized in the Chlamydia pneumoniae inclusion membrane.Chlamydial persistence: beyond the biphasic paradigm.Altered protein secretion of Chlamydia trachomatis in persistently infected human endocervical epithelial cellsPmp-like proteins Pls1 and Pls2 are secreted into the lumen of the Chlamydia trachomatis inclusionModulation of MICA on the surface of Chlamydia trachomatis-infected endocervical epithelial cells promotes NK cell-mediated killing.Identifying catalytic residues in CPAF, a Chlamydia-secreted protease.Identification of Chlamydia trachomatis CT621, a protein delivered through the type III secretion system to the host cell cytoplasm and nucleus.Chlamydia trachomatis-infected epithelial cells and fibroblasts retain the ability to express surface-presented major histocompatibility complex class I molecules.Towards a Chlamydia trachomatis vaccine: how close are we?Structural basis of the proteolytic and chaperone activity of Chlamydia trachomatis CT441.Analysis of CPAF mutants: new functions, new questions (the ins and outs of a chlamydial protease).Recent advances in technologies for developing drugs against Chlamydia pneumoniae.Biomarker candidates of Chlamydophila pneumoniae proteins and protein fragments identified by affinity-proteomics using FTICR-MS and LC-MS/MS.Chlamydia trachomatis infection induces cleavage of the mitotic cyclin B1Secretion of Cpn0796 from Chlamydia pneumoniae into the host cell cytoplasm by an autotransporter mechanism.Activation of Raf/MEK/ERK/cPLA2 signaling pathway is essential for chlamydial acquisition of host glycerophospholipids.Expression and translocation of chlamydial protease during acute and persistent infection of the epithelial HEp-2 cells with Chlamydophila (Chlamydia) pneumoniae.Linkages between oral commensal bacteria and atherosclerotic plaques in coronary artery disease patients.Peptidase Inhibitor 15 (PI15) Regulates Chlamydial CPAF Activity.
P2860
Q30405911-4B64E9BA-2868-4F6E-88C8-5FA4AF2252CCQ30482630-897EA54B-B946-4262-BB0B-4F445584AB5DQ31034927-C8C8E3D8-6629-4DA7-AD65-2F774F436681Q33584064-7A1DB0C3-8348-47ED-977E-C3F1BE7E5BF2Q33730339-3E57B618-0F8F-4CC9-93B9-5B3D1F4313D6Q34756931-0EA0FC97-ED6E-4C21-8271-1A656CB49964Q35138552-A128021F-E017-43CA-AFFC-1420AD9E8721Q35217607-22F241A0-CF54-4C4B-87DF-16F66F79CB58Q35220564-C6A8AA1E-7E1F-4F22-8959-4DEC6C0DB82BQ35688972-F40891F3-5AF1-4AEF-B420-6DE261A6D5EEQ35708475-ED32FAB2-CD78-4C50-9C6B-DF41A4A9D049Q35963835-EB5B130E-292F-48B6-A8C1-56640300543DQ36845220-BFB2B062-EA68-4843-9AD5-49F6EA1DEE82Q37268070-9CCBCB4E-6F86-441B-94D5-07294E617A6BQ37401433-80CF188D-9878-473B-A8A0-51C7C88C4601Q37442460-DD3D800E-6783-4B6D-A946-15D3CFD64582Q37643904-EC132811-182C-4EFA-852A-49A8ACB6BC8CQ37820669-A9E274AF-58B0-404B-9806-2EE6060E4EC6Q37843172-0B7C16D6-802E-4B01-9284-016BBFF6E5E1Q37844146-B76A7172-9515-450E-B47C-6D232B704813Q37844406-120BE842-0924-446E-97A4-0D5E29708FB7Q37851030-962B3862-DF11-4A7D-A14F-529811CE9114Q37861412-AB310BB0-A7F3-4E08-AD8B-69492DFFDEBCQ37864878-0071617C-564D-4030-A430-D017FC3F0D53Q37868030-E47BC7D1-0F18-47AC-A8AB-03E91E2BC02AQ37869596-4E7A1D79-6C1A-441D-8AFD-E24DE217E095Q38709537-C60B66F4-135F-4D12-B12E-6E7A193DB872Q55487839-0B53D31D-AA8B-469B-B663-53DD2B8A9317
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Characterization of a secreted Chlamydia protease.
@ast
Characterization of a secreted Chlamydia protease.
@en
type
label
Characterization of a secreted Chlamydia protease.
@ast
Characterization of a secreted Chlamydia protease.
@en
prefLabel
Characterization of a secreted Chlamydia protease.
@ast
Characterization of a secreted Chlamydia protease.
@en
P2093
P2860
P50
P1476
Characterization of a secreted Chlamydia protease.
@en
P2093
Allan C Shaw
Brian B Vandahl
Gunna Christiansen
Peter Roepstorff
Svend Birkelund
P2860
P304
P356
10.1046/J.1462-5822.2002.00200.X
P577
2002-07-01T00:00:00Z